Oncolytics Biotech, Inc. (ONCY)
0.5476
+0.01
(+1.75%)
USD |
NASDAQ |
Oct 15, 16:00
0.5485
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech Cash from Operations (TTM) : -26.52M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.52M |
| March 31, 2026 | -22.71M |
| December 31, 2025 | -19.95M |
| September 30, 2025 | -18.89M |
| June 30, 2025 | -17.82M |
| March 31, 2025 | -18.50M |
| December 31, 2024 | -19.48M |
| September 30, 2024 | -18.78M |
| June 30, 2024 | -19.44M |
| March 31, 2024 | -20.81M |
| December 31, 2023 | -21.08M |
| September 30, 2023 | -20.96M |
| June 30, 2023 | -19.72M |
| March 31, 2023 | -18.83M |
| December 31, 2022 | -17.98M |
| September 30, 2022 | -18.63M |
| June 30, 2022 | -18.34M |
| March 31, 2022 | -18.46M |
| December 31, 2021 | -17.92M |
| September 30, 2021 | -17.29M |
| June 30, 2021 | -18.93M |
| March 31, 2021 | -17.91M |
| December 31, 2020 | -16.45M |
| September 30, 2020 | -17.55M |
| June 30, 2020 | -16.37M |
| Date | Value |
|---|---|
| March 31, 2020 | -15.41M |
| December 31, 2019 | -15.01M |
| September 30, 2019 | -12.84M |
| June 30, 2019 | -12.11M |
| March 31, 2019 | -8.101M |
| December 31, 2018 | -9.198M |
| September 30, 2018 | -8.406M |
| June 30, 2018 | -8.255M |
| March 31, 2018 | -12.09M |
| December 31, 2017 | -11.43M |
| September 30, 2017 | -11.75M |
| June 30, 2017 | -11.54M |
| March 31, 2017 | -10.19M |
| December 31, 2016 | -9.407M |
| September 30, 2016 | -9.782M |
| June 30, 2016 | -9.648M |
| March 31, 2016 | -11.78M |
| December 31, 2015 | -11.79M |
| September 30, 2015 | -11.48M |
| June 30, 2015 | -13.35M |
| March 31, 2015 | -14.49M |
| December 31, 2014 | -17.87M |
| September 30, 2014 | -19.15M |
| June 30, 2014 | -21.36M |
| March 31, 2014 | -21.05M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Sangamo Therapeutics, Inc. | -90.34M |
| Sarepta Therapeutics, Inc. | 93.95M |
| Anixa Biosciences, Inc. | -7.376M |
| Mera Pharmaceuticals, Inc. | -- |